Clinical

The rule would establish a framework for a telehealth controlled substance registry and authorize three types of special registration. Some industry groups have voiced concerns for providers in their initial reactions to the proposed rule.

The U.S. Food and Drug Administration has published updated draft recommendations to help improve the performance of pulse oximeters across skin tones.

As one telemedicine CEO looks to the year ahead, he predicts RPM will improve outcomes for congestive heart failure patients and help manage those on the wildly popular GLP-1 diabetes and weight loss medications.